These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8068944)

  • 41. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential and synergistic effects of human granulocyte-macrophage colony-stimulating factor and human granulocyte colony-stimulating factor on hematopoiesis in human long-term marrow cultures.
    Hogge DE; Cashman JD; Humphries RK; Eaves CJ
    Blood; 1991 Feb; 77(3):493-9. PubMed ID: 1703795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
    Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
    Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences between normal and CML stem cells: potential targets for clinical exploitation.
    Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
    Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation.
    Robinson S; Lenfant M; Wdzieczak-Bakala J; Melville J; Riches A
    Cell Prolif; 1992 Nov; 25(6):623-32. PubMed ID: 1457609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
    Genevay MC; Mormont C; Thomas F; Berthier R
    Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
    Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
    Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.
    Eaves AC; Cashman JD; Gaboury LA; Kalousek DK; Eaves CJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5306-10. PubMed ID: 3460093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta.
    Cashman JD; Eaves AC; Raines EW; Ross R; Eaves CJ
    Blood; 1990 Jan; 75(1):96-101. PubMed ID: 2403823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro effect of acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation.
    Gaudron S; Grillon C; Thierry J; Riches A; Wierenga PK; Wdzieczak-Bakala J
    Stem Cells; 1999; 17(2):100-6. PubMed ID: 10195570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
    Watanabe T; Brown GS; Kelsey LS; Yan Y; Jackson JD; Ewel C; Kessinger A; Talmadge JE
    Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors.
    Agarwal R; Doren S; Hicks B; Dunbar CE
    Blood; 1995 Mar; 85(5):1306-12. PubMed ID: 7532038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
    Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
    Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor.
    Issaad C; Vainchenker W
    Blood; 1994 Nov; 84(10):3447-56. PubMed ID: 7524739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.
    Eaves CJ; Cashman JD; Kay RJ; Dougherty GJ; Otsuka T; Gaboury LA; Hogge DE; Lansdorp PM; Eaves AC; Humphries RK
    Blood; 1991 Jul; 78(1):110-7. PubMed ID: 1712638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
    Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells.
    Dowding C; Guo AP; Osterholz J; Siczkowski M; Goldman J; Gordon M
    Blood; 1991 Jul; 78(2):499-505. PubMed ID: 1906352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
    Udomsakdi C; Eaves CJ; Swolin B; Reid DS; Barnett MJ; Eaves AC
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6192-6. PubMed ID: 1631107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitors.
    Massé A; Ramirez LH; Bindoula G; Grillon C; Wdzieczak-Bakala J; Raddassi K; Deschamps de Paillette E; Mencia-Huerta JM; Koscielny S; Potier P; Sainteny F; Carde P
    Blood; 1998 Jan; 91(2):441-9. PubMed ID: 9427696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia.
    Udomsakdi C; Eaves CJ; Lansdorp PM; Eaves AC
    Blood; 1992 Nov; 80(10):2522-30. PubMed ID: 1384787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.